|
|
- さやな のしろ
- 7 years ago
- Views:
Transcription
1
2
3
4
5
6 1) Goldblatt. &. Moritz:J. of. Exp. Med., 42, 499 (1925) 2) Mellanby. &. Killick:Biochem. J., 20, 902 (1926) 29) Huldschinsky:Zeitschr. f.orthopad.chirurgie, 39, 426 (1920) 30) Huldschinsky:Deutsch. Med. Wochenschr., 26, 712 (1919) 31) Huldschinsky:Strahlen Therapie, Bd (1929) 32) Huldschinsky:Strahlen Therapie, XI, 435 (1920) 33) Huldschinsky:Monatschr. f. Kindheilk., 38, 52 (1928) 34) Huldschinsky:K1. Wochenschr., 42, 1972 (1926) 35) Hess:J. Am. Med. Assoc., 80, 687 (1923)3 6) Hess:J. Am. Med. Assoc., 89, ) (1927). Hess:J. Biol. Chem.; 62, 301 (1924) 38) Hess:J. Biol. Chem., 63, 297 (1925) 39) Hess:J. Biol. Chem., 66, 145 (1925) 40) Hess:J. Biol. Chem., 67, 413 (1926) 41) Hess:J.Biol. Chem., 70, 123 (1926) 42) Hess:J. Biol. Chem., 13, 145 (1927) 43) Hess:J. Biol. Chem., 14, 651 (1927) 44) Peermer:Strahlen Therapie,Bd. 24, 378(1927) 45) Gyorgy : K1. Wochenschr., No. 23, 1118 (1925) 46) Gyorgy : Monatschr. f. Kindheilk., 38, 31 (1928) 47) Dorno : Strahlen Therapie, Bd. 25, 351 (1927) 48) Beumer : Monatschr. f. Kindheilk., 38, 44 (1928) 49) Jundel : Monatschr. f. Kindheilk., 38, 59 (1928) 50) Dannmeyer : K1. Woocenschr., No. 30, 1372 (1926) 51) Keller : Strahlen Therapie, Bd. 34, 129(1929) 52) Keller : Strahlen Therapie, Bd. 17, 420(1924) 53) Maughan : Am. J. Physiol., 81, 381 (1928) 54) Hausser : Strahlen Therapie, Bd. 13, 41 (1922) 61) Vollmer : Zeitschr. f. Kindheilk.,.45, 265 (1928) 62) Vollmer : Monatschr. f. Kimdheilk., 38, 70 (1928) 63) Mc. Collum : J. Biol. Chem., 45, 333 (1921) 64) McCollum : J. Biol. Chem., 51, 41 (1922) 65) McCollum : J. Biol. Chem., 53, 293 (1922) 66) McCollum : Am. J. dis. of Child, 33, 230 (1927) 67) McCollum : The newer Knowledge of nutrition (1939)
7
8
9
10
11
12
13 1) Shohl : J. of Nutrition, 14, 69 (1937) 2) Hamilton a. Dewer : Am. J. Dis. Child, 54,. 548 (1937) 3) Hathaway a. Meyer : J. of Nutrition, 11,. 417 (1939) 4) E. Rominger : Kl. Wochenschr., 28, 1293 (1931) 5) E. Rominger : 5.Intern. Cong. of Pediat. 36, 336 (1947) 6) Harrison : J. of Pediat., 41, 756 (1952)
89 91 93 95 97 99 101 103 105 107 109 111 113 115 H 117 119 l l 121 l l 123 125 127 129 l l l l 131 kl kl kl kl 133 135 137 139 141 143 145 147 149 151 153 155 157 159
More information株式会社日清製粉グループ本社 第158期中間事業報告書
C O N T E N T S...1...3...5...7...9...11...12...13...14 1 2 3 4 3.7% 5.8% 8.5% 70,100kL 81.2% 0.8% 25 20 15 10 5 0 9.18 9.54 9.74 9.62 9.65 9.71 21.04 21.97 22.44 22.23 8.54 22.31 22.45 20.41 15 12 9 6
More information日本皮膚科学会雑誌第122巻第2号
J Dermatol Sci Vitam Horm NEnglJMed Lancet J Clin Invest Antitoxid Redox Signal Diabetes Metab Res Rev Diabetes Care Diabet Med Diabetes care Diabetes Care J Foot Ankle Surg Wound Repair Regen Lancet Foot
More information2006年3月8日
18 21 1990 2004 2 2005 14 15 2004 1990 2005 2003 300 7 2 1 2005 1972 100 40 6 1972 2004 197 6,500 2004 21 59 100 65 2007 5 2005 30 1.8 535.89 348.33 187.56 2006 2006 5 1 30 1 30 46 46 1 46 1000kl 4 1 100kl
More information97_shigeo-nakayama-j.PDF
114 114 6240 900-1- 4 2 1 5 2 5 12-2- 1 2 2 24 3 2 7 9 1 15 7 9 4 4 1 7 160-3- -4-1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 1 20 25 5 1 2 3 4 5 6 45m 30m 3m 24 1 3 6 1 2 12 3 4
More information:010_ :3/24/2005 3:27 PM :05/03/28 14:39
:010_896300101703 :3/24/2005 3:27 PM :05/03/28 14:39 :010_896300101703 :3/24/2005 3:27 PM :05/03/28 14:39 :010_896300101703 :3/24/2005 3:27 PM :05/03/28 14:39 :010_896300101703 :3/24/2005 3:27 PM :05/03/28
More informationComplex sleep apnea syndrome and sleep disordered breathing in patients with cardiovascular disease V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) Sleep J Clin
More informationl
1949 3 1963 5 ()1 10 32 7395 1844 15 8 31 100 200 100 500 2001 4000 1 2 3 4 5 6 7 8 9 1 1998 p xi 2 p1711 3 [] 4 J-Net21 Q&A -[] http://j-net21.jasmec.go.jp/qa/qa080109.html 5 [].101 6 [] 7 8 146
More information2
1 2 3 4 23 26 1.821.42 5 6 7 8 9 10 11 (kw) 50.0 10.0 5.5 20.0 20.0 50.0 5.0 32.0 22.0 10.2 224.7 12 13 m3 14 15 16 17 18 19 20 21 22 23 24 25 12 26 27 L=50m 28 29 30 31 32 33 34 35 36 37 kl/ 年 kl/ 年 kl/
More informationuntitled
Fig.1 t O O N,N p n J J J J J t J J J J J J J J J J J t t J J J J J J J J J p Fig.2 p t Fig.3 Fig.4 synanti p Table1 Table2t Table2 synanti antisyn synanti synanti Fig.5 syn anti anti Fig.6 Table3 Table4
More informationThe Heart Healthy Tocotrienol Complex Tocomin SupraBio
The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio 1. Fact Sheet No. 317; World Health Organization (WHO), 2007 2. LLOYD-JONES D. et al. Circulation
More informationSachiko Sugimoto Pascheff28), Fort12), Lehrfeld4), Seefelder u. Berger recht24), Meyer25), Bayer226), Giese u. Bruckner27), 1) Saemisch: Handbuch d. Augenheilkunde II Aufl., Bd. 5, S. 467 (1871)
More information3 4
2 3 4 5 6 Contents 117 9 30 10 00 10 30 12 00 13 30 15 30 1700 15 00 9 30 10 00 Contents 118 11 30 13 00 14 30 15 00 1630 7 22 36 8 7 Report MC 2000 Report MC 2000 10 9 12 11 14 13 16 15 18 17 20 19 22
More information1) Michaelis L. Biochem Z., 59, 78, 1914. 2) Ferris H. C. Dent. Cosmos Phila., 63, 10, 93, 1921. 3) Bloomfield A. L. Bull Johns Hopk. Hosp. Bait., 31, 118, 1920. 4) Starr H. C. J. Biol. Chem. Bait., 54,
More informationuntitled
80 81 10.6% 2.6% 82 21.1% 29.6% 83 6.2% 4.9% 84 61.7% 59.6% 7.8% 85 86 A B C D (BD 100) % % % A B C D (BD 100) 46.6% 88 53.5% 89 90 40.5% 34.4% 91 30% 30% 30% 93 40.9% 31.4% 28.6% 28.1% 27.8% 97 98
More information48 * *2
374-1- 17 2 1 1 B A C A C 48 *2 49-2- 2 176 176 *2 -3- B A A B B C A B A C 1 B C B C 2 B C 94 2 B C 3 1 6 2 8 1 177 C B C C C A D A A B A 7 B C C A 3 C A 187 187 C B 10 AC 187-4- 10 C C B B B B A B 2 BC
More informationAUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urol
AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urology, Kumamoto University College of Medicine (Director:
More information…h…L…–…†…fi…g1
21 1326 1328 2002 22 4375 4377 2003 34 6 848 849 2005 9 10 15 1067 1070 1996 49 133 166 2003 1 2 2 3 4 4 1 3 23 311 313 2004 5 1 118 7604 7607 1996 15 1 33 6627 6629 2000 12 649 155 167 2003 76 23 7007
More information日本皮膚科学会雑誌第121巻第11号
β Clin Rheumatol Arthritis Rheum Am J Cardiol J Rheumatol J Rheumatol Arthritis Rheum Arthritis Rheum Arthritis Rheum Rheumatology Oxford Rheumatology Oxford Br J Dermatol Arch Dermatol Ann Rheum Dis
More informationuntitled
-1- -2- -3- AED -4- 2-5- -6- -7- -8-6-1-28 048-833-1231 2-1-1 048-261-3119 4389-1 048-556-3005 1-13-11 04-2924-1311 2097-1 048-738-3111 1172 04-2953-7111 990-1 048-565-1919 537 048-775-1311 2-2-2 048-924-2111
More informationclover-375.pdf
8:4511:00 9:0012:30 9:0016:3003-5986-3188 AM PM AM PM AM PM AM PM AM PM AM PM - - - - - - 1 2 3 5 6 7 8:4515:00 9:0016:30 AM PM AM PM AM PM AM PM AM PM AM PM - - - - - - - - - () - - - - - - - 8 10 12
More informationEds and Hamet gefunden, und wird von Hamet auf die Verschiedenheit der Angriffs punkte des Ephedrins und des Adrenaline zuzuckgefuhrt. Verf. fuhrt die
Aus den Pharmakologischen Institut der Okayama Medizinischen Fakultat (Vorstand: Prof. Dr. K. Okushima). Beitrage zur Wirkung des Adrenalins, Ephedrins, und Adrenalons auf den Blutdruck, im Vergleich zu
More informationAus der I. Chirurgischen Klinik der Okayama Medizinischen Fakultat (Direktor: Prof. Dr. G. Izumi). Uber die Beziehungen zwischen der Wass
612. 357. 71 Aus der I. Chirurgischen Klinik der Okayama Medizinischen Fakultat (Direktor: Prof. Dr. G. Izumi). Uber die Beziehungen zwischen der Wasserstoffionen-Konzentration der Galle und der Gallenblasenfunktion.
More informationVol.40 No.5△/△0 目次[三]10.23
! Department of Management, Miyagi University, 2 2 1 Hatatate Taihaku-ku Sendai, Miyagi 982 0215 Industrial Technology Institute, Miyagi Prefectural Government, 2 2 Akedoori Izumi-ku Sendai, Miyagi 981
More information! 1Munderl P et al. Survival and causes of death, 2 years after Introduction of antiretroviral therapy in Africa. XVI International AIDS Conference, 2006, Abstract THLB0208. 2Walensky RP et al. The
More informationCorrelation between molecular evolution of P450s and evolution of plant secondary metabolism Masaharu Mizutani E-mail : mizutani@scl.kyoto-u.ac.jp URL : http://biofun.kuicr.kyoto-u.ac.jp/index-j.html 13)
More information1) van Meer, G., Op den Kamp, J. A.: J. Cell. Biochem., 19, 193-2040982) 2) Gaffet, P., Bettache, N., Bienvenue, A.: Biochemistry, 34, 6762-6769(1995) 3) Sims, P. J., Wiedmer, T.: Thromb. Haemost., 86,
More information社会環境報告書
SUSTAINABILITY REPORT 2010 CONTENTS 01 SUSTAINABILITY REPORT 2010 300,000 200,000 100,000 250,719 239,575 227,421 276,797 261,586 165,902 190,319 180,119 157,824 157,722 12,000 8,000 4,000 7,620 5,661
More informationuntitled
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Int J Radiat Oncol Biol Phys 49 Cancer 101 Int J Radiat Oncol Biol Phys 60 Chest 124 Int J Radiat Oncol Biol Phys 56 Int J Radiat Oncol Biol Phys 49 Chest 124 Int J
More informationEffect of Supplementation of Sulfur-Containing Amino Acids to a Low-Soy Protein Diet Containing Cholesterol on Plasma Cholesterol Levels in Rats Tokik
Effect of Supplementation of Sulfur-Containing Amino Acids to a Low-Soy Protein Diet Containing Cholesterol on Plasma Cholesterol Levels in Rats Tokiko MIZUNO, Hiroko ABE, Ryuji HIRANO and Koji YAMADA
More informationNovel chemical mediators in the resolution of inflammation Charles N. Serhan Key words E-mail : marita@nih.go.jp Charles N. Serhan Brigham & Women's Hospital/Harvard Medical School 1) Serhan, C. N.,
More information1) Budinger: Deutsch. Zeitschr. f. Chir. Bd. 90, S 532, 1907. 2) Katzenstein: Kongr. deutsch Geselsch. f. Chir. B. I, Teil X. 3) A. v. Lichtenberg: Handbuch. d. Urolog., V, spez. Urolog. III, 745. 4) Young,
More information1) V. Hinsberg: Die tympanogene Labyrinthentzundung (Denker-Kahler's Handb. Bd. VII S. 448 (1926). 2) W. Uffenorde: Die chirurgischen Erkrankungen des inneren Ohres. (Katz-Blumenfeld's Handb. Bd. II. S
More informationStudies on the Liver Function in special Reference to the Influence of Steroidhormone By Tadahiko KUME Third Department of Internal Medicine (Director
Studies on the Liver Function in special Reference to the Influence of Steroidhormone By Tadahiko KUME Third Department of Internal Medicine (Director : T. MASUYA) Faculty of Medicine, Kyushu University,
More informationdrug development Toshimi Michigami, E-mail : michigami@mch.pref.osaka.jp Keiichi Ozono, E-mail : keioz@ped.med.osaka-u.ac.jp The progress in the research on vitamin D 1) McCollum, E. V. et al.:
More informationet al No To Shinkei Clin Neurol Neurology et al J Neurosurg et al Arch Neurol et al Angiology
37 Recommendations for the Management of Moyamoya Disease A Statement from Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) Research on intractable diseases of the
More information表1.eps
Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol
More informationDatabase Center for Life Science Online Service Structure and function of nitric oxide synthases
Structure and function of nitric oxide synthases 3) Furchgott, R. F., Zawadzki, J. V. : Nature, 288,373-376 (1980) 4) Palmer, R. M., Ferrige, A. G., Moncada, S.: Nature, 327,524-5260987) 5) Alderton,
More information109
108 1 2 3 109 110 111 112 1 c c < c c< B N a d 1 2 3 5 8 9 0 ; 2c< rc a h 3c 113 1p 2c< 3c< a r 4cc 1p 2 c 3c< c p a c 4p 5 c rr c c Cr m e 114 1 c c < c< B N d a 1 3 5 9 0 ; 2c< B ; p c< BN50; ar h 3c
More informationTable 1 Age Adjusted Mortality in CHD(1985) (rate/ person/year) Fig. 1 The Cause of Death. (K. Uemura, Z. Pisa)
The Forefront of Lipid Nutrition Kazuo KONDO and Tamami IWAMOTO The National Institute of Health and Nutrition (1-23-1, Toyama, Shinjyuku-ku Tokyo, 162) Abstract : The mortality of heart disease in Japan
More informationFragaria x ananassa Bioengineering College of Jimei University, Jimei, Xiamen 361021, Fujian Province, China Department of Food Science and Technology, Tokyo University of Marine Science and Technology,
More informationEK L M A A B C H I D E F G A B C I J A B C z D E F G D F G
EK L M A A B C H I D E F G A B C I J A B C z D E F G D F G H I J K L M z A A B C A z z z z A B z z v zv z z A B C z z z z A B z A A B A B C D C D A B C A B A B C A B A A A B C A A F B G H I J KL M N P
More informationuntitled
( 1,000 1 0562-92-8317 0562-93-8105 12 1000 133015303/25 10 700 90011303/30 100 0 100011303/25 1 30 2 30 3 1 12 5 3000 7000 9001130 5/135/276/37/88/5 1 2 35 2 10 5 3000 5000 3 9001130 6/86/227/68/249/21
More informationActa Chem Scand Acta Endocrinol Acta Haematol Acta Haematol Jpn Acta Histochem(Jena) Acta Med Scand Acta Neurol Scand Acta Neuropathol Acta Paediatr S
編集部から投稿者へのお願い ( 平成 25 年 10 月改訂 ) 1. 共著者として氏名を記載できるのは会員に限りますので 入会手続きをされない場合はその共著者の氏名は削除させていただきます 2. 著者名には ふりがなを付けて下さい 3. 図表の表題および説明 (legend) は原則英文でつけて下さい 図はそのまま印刷製版できる明瞭なものとしてください 4. 引用文献の書き方は 次のようにして下さい
More information437“ƒ
et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer
More information2 Excel =sum( ) =average( ) B15:D20 : $E$26 E26 $ =A26*$E$26 $ $E26 E$26 E$26 $G34 $ E26 F4
1234567 0.1234567 = 2 3 =2+3 =2-3 =2*3 =2/3 =2^3 1:^, 2:*/, 3:+- () =2+3*4 =(2+3)*4 =3*2^2 =(3*2)^2 =(3+6)^0.5 A12 =A12+B12 ( ) ( )0.4 ( 100)0.9 % 1 2 Excel =sum( ) =average( ) B15:D20 : $E$26 E26 $ =A26*$E$26
More information13_高さ制限
#'(!"#$)*56+,-./01 222'(3456789:%;?@A?BCD!"#$%& () () 1. 1.25 2.3.1.5 ()() " 1.25 1.5) 1.25 or 1.5 1! 5 2)! 3)!562 7 8 !13012 2.5m 5 1/5 1m 5m 1/5 1m 2m 1.2m 9 4)!6132 35m 10m 10... A B 2A35m 12 1322
More information2007 Vol.56 No.6 総説 丸山浩樹
Reprinted from RADIOISOTOPES, Vol.56,.6 June 2007 Japan Radioisotope Association http : //www.jrias.or.jp/ α β α β ε m z α µ µ α m z m z µ µ Curr. Opin. Biotechnol J. Proteome Res Rapid Commun. Mass
More information日本皮膚科学会雑誌第122巻第7号
Br J Dermatol NEnglJ Med 尋常性白斑診療ガイドライン 図 1 先天性白斑 白皮症の病型分類 図 2 後天性白斑 白皮症の病型分類 の尋常性白斑患者で家系内発症がみられることより 3 5 れらの合併が染色体 17p13 における一塩基多型に起 非分節 因し その候補遺伝子の一つが自然免疫に重要とされ 型に含まれる汎発型には甲状腺に対する抗サイログロ る NALP1 遺伝子であると報告している6
More informationR Hecker, Beitrag zur Histologie u. pathologie d. cong. syphilis sowie fur normalert trat d. Fatus u. neuge- 5) Forster, Beitrage zur path Anatomie d. cong syphilis munch. med Woch. schr Nr. 49, 1885.
More information平成19年度決算参考資料
[] 19 1. 1 2. 2 3. 4 1. 5 2. 8 3. 9 19 10 19 1. 1 2. 4 3. 4 4. 5 5. 6 6. 8 7. 9 8. 10 9. 10 10. 10 11. 11 1. 13 2. 16 3. 17 4. 18 5. 19 6. 23 7. 23 8. 24 9. 31 10. 32 11. 33 12. 34 19 19 35 1. 36 2. 37
More informationりそなホールディングス2005年3月期半期報告書
:000_3_0889500501612 :12/28/2004 10:23 AM:04/12/28 10:44 :000_4_0889500501612 :12/28/2004 10:24 AM:04/12/28 10:47 :000_header_0889500501612 :12/28/2004 10:24 AM:04/12/28 10:47 :010_0889500501612 :12/28/2004
More informationマ ウ スの病 態 生 理 に 関 す る実 験 的 研究 表4 従 つ てCa排 泄 量 は,対 痙 攣 群 で 約60%多 く,ま 尿17-Hydroxycorticosteroidl 照 のCF-1系 マウスより た 未 痙 攣 群 よ り約7.5%痙 に 述 べ た 方 法 に 従 つ て 総 量 遊 離 型 結 合 型 に わ け て 得 た 成 績 を 示 せ ば 表4の お, マ ウ
More informationuntitled
() 5 8 80% 17 2 366 3,300 () CO2 17 10 1000kWh =0.257KL 1000 =1.16KL 80% 40% 30% 20% 278,000kWh ON 26 22 ON 2 1 1 1 4-2 OFF ON 2 1 1 kw \ \ 1 1 ( 1 1 ( 40) 2 10 ()10 ) 1 (100V) (200V) kwh kwh 1kWh 1kWh
More informationアナリティカルVol8
Wako 19983 32 50 50 518 100 10 11 640 12 r 1 4 6 R 3 78 R 2 R 1 2 3 4848 1000 20314141 1r 4000 20914143 3r 9000 08307391 n 1r 3500 04826321 1r 04426323 3r 209 13 p 3344 33445 334455 23344 23445 23445 23445
More information取扱説明書[N-02B]
187 1 p p 188 2 t 3 y 1 1 p 2 3 4 5 p p 1 i 2 189 190 1 i 1 i o p d d dt 1 2 3 4 5 6 9 0 191 192 d c d b db d 1 i 1 193 194 2 d d d r d b sla sla 1 o p i o o o op 195 u u 1 u t 1 i u u 1 i 196 1 2 bd t
More information™…{,
57 th Annual Meeting of The Japanese Society of Child Health The 57th Annual Meeting of the Japanese Society of Child Health 3 4 The 57th Annual Meeting of the Japanese Society of Child Health 5 6 The
More information1) Dalton, A. J. et al. : J. Nat. Cancer Inst., 11 : 439, 1950. 2) Fawcett, D. W.: J. Nat. Cancer Inst., 15 :1475, 1955. 3) Oberling, C. et Rouiller, C.: Ann. d'anat. path., 1: 401, 1956. 4) Palade, G.
More informationBenoit, J. 1923. A propos du changement experimental de sexe par ovariotomie chez la Poule. C. r. Soc. Biol. Paris. 89, 1326 Brode. M. D. 1928 The significance of the asymmetry of the ovaries of the fowl.
More information3) Albright, Baid, Cope, Bloomberg: Am. Jour. Med. Scond 187, 1934. 4) Albright, Sulkowitch, Bloomberg: Arch. Int. Med. 62, 1938. 5) Allegri: Zit. mach Biedle. 6) Anderson: Arch. of Path. 27, 1939. 7)
More informationPEANUTS 2014 Peanuts Worldwide 1 2 3 4 5 6 1 2 3 4 5 6 7 8 9 10 11 MEMO 12 1 2 3 4 MEMO 5 6 7 8 9 10 MEMO 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41
More information5) Kawada T, Hagihara K, Iwai K (1986) Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J Nutr 116 : 1272-8. 6) Kawada T, Watanabe T, Takaishi T, Tanaka T, Iwai K (1986) Capsaicin-induced
More information住まい・まちづくり活動事例集
3 H15 1982 1988 5 H16.31 1 1 1 246 26 3 2003 11 21,417/ 65 17.91% 16.62%1.29 246 2 1 12 1246 5008026 30080 3 200803 120060 2 20013 1 1 21 11 19821988 199112003 13 1988 1 1991 28 3 1991 1993 1992 1 1995
More informationTrypafavin, Pyocutan,in, Mercurochrome Yatren, Trypaflavin, Rivanol, Sin flavin Trypailavin, Sinflavin, A.20,
Trypafavin, Pyocutan,in, Mercurochrome Yatren, Trypaflavin, Rivanol, Sin flavin Trypailavin, Sinflavin, A.20, Chloramin T. etc. hyclrouprein (Optochin, Remijin Isoamylhydrocuprein(Eukupin) 2-Aethooxy-6-9-diaminoacridinhydrochlorid(Rivanol)
More information4) H. Takayama et al.: J. Med. Chem., 45, 1949 (2002). 5) H. Takayama et al.: J. Am. Chem. Soc., 112, 8635 (2000). 6) H. Takayama et al.: Tetrahedron Lett., 42, 2995 (2001). 9) M. Kitajima et al: Chem.
More information2) Cohn, Jahrb. f. Khk., Bd. 37, S. 187, 1918. 3) Elgood, v. Korenchevsky, The aetiology and pathology of rickets from an experimental 11) Kassowitz, Jahrb. f. Khk., Bd. 65, S. 251, point of view, P. 155,
More informationVol.24 No.3
June 1978 Effect of acupuncture on scalp potential evoked by electric tooth pulp stimulation Hiroshi FUJIMOTO Second Department of Oro- maxillo- facial Surgery, School of Dentistry, Aichigakuin University
More information1) Karpatkin, S.: Blood, 51: 307, 1978. 2) Karpatkin, S.: Ann. Intern. Med., 89: 200, 1978. 3) Brecker, C. and Cronkite, E. P.: J. Appl. Phy siol., 3: 365, 1950. 4) Mielke, C. H., Jr., et al.: Blood, 34:
More informationⅡ 防災計画の概要
12 ( 10 304 3 16 14 25 3 ) ( ) 1 3 1 18 12 2 ( ) ( ) 18 12 ( ) ( ( ) ( ) ( ) ( ) 1 ( ) 3 ( ) ( ) ( ) 4 5 1 2 3 ( ) 4 1 1 6 7 3 3 2 3 3 ( ) 1 AM PM 8 9 8 30 8 50 8 50 9 00 9 00 9 50 10 00 11 00 11 00 12
More informationCISPR11 AM J55001(H22)
J55011H27 CISPR 11 5 (2009), Amd.1(2010) J55001(H22) 3 a) CISPR11 26 3 CISPR11 J55011 b) CISPR11 CISPR11 2 CISPR11 CISPR11 CISPR11 CISPR11 CISPR11 c) CISPR11 CISPR11 CISPR11 CISPR11 AM J55001(H22) 1 2
More informationMC-440 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67
More information東大阪地域活性化支援機構活動レポート2015 _061620
!1 NPO 2015 2016 5 16 NPO !2 DIGEST NEWS 2015 2015.04.05 3 10 1 6 2015.08.29 AM 1 1 AM 4 6 IC !3 2015.09.02 AM AM 1 8 29 4 6 AM NPO 1 2003 53 2 65000 13 2015.09.07 AM AM 9/7 12 15 18 22 9/12 9/13 !4 2015.11.24
More informationA study on the inductive mechanism of ovulation with Clomiphene citrate. (especially, at movement in urinary excretion of luteinizing hormone.)
A study on the inductive mechanism of ovulation with Clomiphene citrate. (especially, at movement in urinary excretion of luteinizing hormone.) CHEMICAL STRACTURE OF CLOMIPHENE CITRATE AND RELATED COMPAUND
More information87) Allen. et al.: Am. Rev. Tbc., 68, 136, (1953). 88) Baldwin. et al. Am. Rev. Tbc., 68, 372, (1953). 89) Campagna. et al.. Ibid., 60, 334, (1954). 90) Crawford. et al. Am Rev. Tbc., 30, 568 (1934). 91)
More information3) Z. Nambu: in preparation (1971). 4) N. P. Wilkins & J. D. Iles: Comp. Biochem. Physiol., 17, 1141 (1966). 5) V. M. Ingram: Nature, 235, 338 (1972). Bacillus cereus var. mycoides, Bacillus thuringiensis
More information21 60 Vol. 21 No
3040 90 2 Vol. 21 No. 81999 21 60 Vol. 21 No. 81999 3 4444444444444444444444444444444444444444444444444444444 1830 10 12 1010 18 80 32 4 Vol. 21 No. 81999 Vol. 21 No. 81999 5 6 Vol. 21 No. 81999 Vol. 21
More information日本皮膚科学会雑誌第120巻第8号
1 2 3 4 5 6 付表 1 エビデンスのレベルと推奨度の決定基準 ( 皮膚悪性腫瘍グループ ) A. エビデンスのレベル分類 I I I IV V V I システマティック レビュー / メタアナリシス 1つ以上のランダム化比較試験による非ランダム化比較試験による分析疫学的研究 ( コホート研究や症例対照研究による ) 記述研究 ( 症例報告や症例集積研究による ) 専門委員会や専門家個人の意見
More informationAI n Z f n : Z Z f n (k) = nk ( k Z) f n n 1.9 R R f : R R f 1 1 {a R f(a) = 0 R = {0 R 1.10 R R f : R R f 1 : R R 1.11 Z Z id Z 1.12 Q Q id
1 1.1 1.1 R R (1) R = 1 2 Z = 2 n Z (2) R 1.2 R C Z R 1.3 Z 2 = {(a, b) a Z, b Z Z 2 a, b, c, d Z (a, b) + (c, d) = (a + c, b + d), (a, b)(c, d) = (ac, bd) (1) Z 2 (2) Z 2? (3) Z 2 1.4 C Q[ 1] = {a + bi
More informationFig. 2: No, 66 N., Sasa, M;, Miura, A., and Nishioka, K. 19 52, Studies on Izuri fever-3. Notes on the field mice and their external parasites collected around the fountatinheads in the endemic avea of
More informationFig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad
Key words: Female with bladder irritability, Subjective symptoms, Pyuria, Bacteriuria Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution
More information: Aus dem gerichtsarztlichen Institut der Okayama Medizinischen Fakultat. Experimentelle Untersuchung uber den Stickstoffwechsel b
616-098: 612. 015. 33 Aus dem gerichtsarztlichen Institut der Okayama Medizinischen Fakultat. Experimentelle Untersuchung uber den Stickstoffwechsel bei Kaninchenschistosomiasis japonica. Von Tokujiro
More informationVOL33NO.3/2010 A B A B p-erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 Erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 p-vasp VASP C D enos/gapdh x-fold vs sham 2.0 1.5 1.0 0.5 * 0 ANP (-) (+) (-)
More information